Cover Image
市場調查報告書

冠狀動脈繞道手術:醫療設備的開發平台評估

Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 357845
出版日期 內容資訊 英文 68 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈繞道手術:醫療設備的開發平台評估 Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年04月15日 內容資訊: 英文 68 Pages
簡介

本報告提供冠狀動脈繞道手術相關之開發中產品調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的近幾年趨勢等資訊。

第1章 目錄

第2章 簡介

  • 冠狀動脈繞道手術概要

第3章 開發中的產品

  • 冠狀動脈繞道手術 - 開發中產品:各開發階段
  • 冠狀動脈繞道手術 - 開發中產品:各市場區隔
  • 冠狀動脈繞道手術 - 開發中產品:各地區 (國家)
  • 冠狀動脈繞道手術 - 開發中產品:各法規途徑
  • 冠狀動脈繞道手術 - 開發中產品:各核准時期 (估計)
  • 冠狀動脈繞道手術 - 持續中臨床實驗

第4章 冠狀動脈繞道手術 - 正在開發的開發中產品:各企業

  • 冠狀動脈繞道手術企業 - 開發中產品:各開發階段
  • 冠狀動脈繞道手術 - 開發中產品:各開發階段

第5章 冠狀動脈繞道手術 開發企業與產品概要

  • AdvanSource Biomaterials Corporation
  • Axcelon Biopolymers Corp.
  • CardioPolymers, Inc.
  • CellProthera
  • Coromedic Ltd.
  • Cytograft Tissue Engineering, Inc.
  • Elana bv
  • Endogene Ltd
  • Graft-Loc Inc.
  • H. Lee Moffitt Cancer Center & Research Institute, Inc.
  • iiTech BV
  • Magenta Medical Inc
  • Miracor Medical Systems GmbH
  • Neograft Technologies, Inc.
  • NuVascular Technologies Inc
  • Prekubator TTO
  • Revivicor, Inc.
  • SeamVad Ltd.
  • St. Jude Medical, Inc.
  • Tengion, Inc.
  • The University of Utah
  • Tissue Regeneration Technologies, LLC
  • University College London
  • University of Arizona
  • University of California, Los Angeles

第6章 冠狀動脈繞道手術 - 近幾年趨勢

第7章 附錄

目錄
Product Code: GDME0167EPD

GlobalData's Medical Devices sector report, "Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Coronary Artery Bypass Graft Surgery Overview

3. Products under Development

  • 3.1. Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • 3.2. Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
  • 3.3. Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
  • 3.4. Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
  • 3.5. Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
  • 3.6. Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials

4. Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies

  • 4.1. Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
  • 4.2. Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development

5. Coronary Artery Bypass Graft Surgery Companies and Product Overview

  • 5.1. AdvanSource Biomaterials Corporation Company Overview
    • 5.1.1. AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Axcelon Biopolymers Corp. Company Overview
    • 5.2.1. Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. CardioPolymers, Inc. Company Overview
    • 5.3.1. CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. CellProthera Company Overview
    • 5.4.1. CellProthera Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Coromedic Ltd. Company Overview
    • 5.5.1. Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Cytograft Tissue Engineering, Inc. Company Overview
    • 5.6.1. Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Elana bv Company Overview
    • 5.7.1. Elana bv Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Endogene Ltd Company Overview
    • 5.8.1. Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Graft-Loc Inc. Company Overview
    • 5.9.1. Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview
    • 5.10.1. H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. iiTech BV Company Overview
    • 5.11.1. iiTech BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Magenta Medical Inc Company Overview
    • 5.12.1. Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Miracor Medical Systems GmbH Company Overview
    • 5.13.1. Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Neograft Technologies, Inc. Company Overview
    • 5.14.1. Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. NuVascular Technologies Inc Company Overview
    • 5.15.1. NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Prekubator TTO Company Overview
    • 5.16.1. Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Revivicor, Inc. Company Overview
    • 5.17.1. Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. SeamVad Ltd. Company Overview
    • 5.18.1. SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. St. Jude Medical, Inc. Company Overview
    • 5.19.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Tengion, Inc. Company Overview
    • 5.20.1. Tengion, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. The University of Utah Company Overview
    • 5.21.1. The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Tissue Regeneration Technologies, LLC Company Overview
    • 5.22.1. Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. University College London Company Overview
    • 5.23.1. University College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. University of Arizona Company Overview
    • 5.24.1. University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. University of California, Los Angeles Company Overview
    • 5.25.1. University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

6. Coronary Artery Bypass Graft Surgery- Recent Developments

  • 6.1. Jan 04, 2016: Cellular Regenerative Therapy Greeted by French Minister of Health
  • 6.2. Dec 15, 2015: Cardiac Dimensions Announces Appointment Of Gregory D. Casciaro As President And Chief Executive Officer
  • 6.3. Aug 27, 2015: Bioheart to Change Name to U.S. Stem Cell, Inc.
  • 6.4. Aug 06, 2015: Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results
  • 6.5. May 20, 2015: Primary Lesion Treatment Using Diamondback 360 Orbital Atherectomy System Enhances Paclitaxel Deposition in Calcified Peripheral Arteries: Preclinical Data Presented at EuroPCR 2015
  • 6.6. May 19, 2015: Cardiovascular Systems Peripheral and Coronary Data Featured at EuroPCR 2015
  • 6.7. May 12, 2015: Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 Results
  • 6.8. May 06, 2015: Bioheart Highlights Positive First Quarter Results

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Table 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
  • Table 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
  • Table 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
  • Table 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
  • Table 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
  • Table 7: Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
  • Table 8: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Table 9: AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: CardioPass - Product Status
  • Table 11: CardioPass - Product Description
  • Table 12: AdvanSource Biomaterials Corporation - Ongoing Clinical Trials Overview
  • Table 13: CardioPass - CardioPass - European Clinical Trial
  • Table 14: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: BNC - PVA Based Vascular Graft - Product Status
  • Table 16: BNC - PVA Based Vascular Graft - Product Description
  • Table 17: CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Plexisyl-AF - Product Status
  • Table 19: Plexisyl-AF - Product Description
  • Table 20: CellProthera Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: CellProthera Automated Device - Product Status
  • Table 22: CellProthera Automated Device - Product Description
  • Table 23: Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Distal Anastomosis Device - Product Status
  • Table 25: Distal Anastomosis Device - Product Description
  • Table 26: Proximal Anastomosis Device - Product Status
  • Table 27: Proximal Anastomosis Device - Product Description
  • Table 28: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: LifeLine TEBV - CABG - Product Status
  • Table 30: LifeLine TEBV - CABG - Product Description
  • Table 31: Elana bv Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Artificial Vessel - Product Status
  • Table 33: Artificial Vessel - Product Description
  • Table 34: Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Cardio-Vascular Stapling Instrument - Product Status
  • Table 36: Cardio-Vascular Stapling Instrument - Product Description
  • Table 37: Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Graft-Loc Device - Product Status
  • Table 39: Graft-Loc Device - Product Description
  • Table 40: H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Vascular Stent - Product Status
  • Table 42: Vascular Stent - Product Description
  • Table 43: iiTech BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: S² Distal Anastomotic System - Product Status
  • Table 45: S² Distal Anastomotic System - Product Description
  • Table 46: S² Proximal Anastomotic System - Product Status
  • Table 47: S² Proximal Anastomotic System - Product Description
  • Table 48: Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Magenta Device - Congestive Heart Failure - Product Status
  • Table 50: Magenta Device - Congestive Heart Failure - Product Description
  • Table 51: Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: PiCSOAMI Impulse Console - CABG - Product Status
  • Table 53: PiCSOAMI Impulse Console - CABG - Product Description
  • Table 54: Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Angioshield - Product Status
  • Table 56: Angioshield - Product Description
  • Table 57: Neograft Technologies, Inc. - Ongoing Clinical Trials Overview
  • Table 58: Angioshield - Feasibility Study to Demonstrate the Safety of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery: THE ANGIOSHIELD STUDY
  • Table 59: Angioshield - First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery
  • Table 60: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: BioFunc - APC Vascular Graft - Product Status
  • Table 62: BioFunc - APC Vascular Graft - Product Description
  • Table 63: Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Snapcon - Product Status
  • Table 65: Snapcon - Product Description
  • Table 66: Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Blood Vessel - Product Status
  • Table 68: Blood Vessel - Product Description
  • Table 69: SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: MySide - Product Status
  • Table 71: MySide - Product Description
  • Table 72: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Automated Anastomosis Device - Product Status
  • Table 74: Automated Anastomosis Device - Product Description
  • Table 75: Tengion, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Neo-Vessel Replacement - Coronary Artery Bypass - Product Status
  • Table 77: Neo-Vessel Replacement - Coronary Artery Bypass - Product Description
  • Table 78: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Automated Arterial Anastomotic Device - Product Status
  • Table 80: Automated Arterial Anastomotic Device - Product Description
  • Table 81: Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Cardiogold - Product Status
  • Table 83: Cardiogold - Product Description
  • Table 84: University College London Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Small Diameter Conduit - Product Status
  • Table 86: Small Diameter Conduit - Product Description
  • Table 87: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: Vascular Anastomosis Device - Product Status
  • Table 89: Vascular Anastomosis Device - Product Description
  • Table 90: University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Sutureless Anastomosis Device - Product Status
  • Table 92: Sutureless Anastomosis Device - Product Description
  • Table 93: Glossary

List of Figures

  • Figure 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Figure 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
  • Figure 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
  • Figure 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
  • Figure 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
  • Figure 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
Back to Top